This is a preview of subscription content, log in via an institution to check access.
References
Woodcock J. Statement from Janet Woodcock, M.D., director of FDA's Center for Drug Evaluation and Research, on impurities found in diabetes drugs outside the U.S. Internet Document : 5 Dec 2019. Available from: URL: https://www.fda.gov/news-events/press-announcements/statement-janet-woodcock-md-director-fdas-center-drug-evaluation-and-research-impurities-found
EMA. EMA update on metformin diabetes medicines. Internet Document : 6 Dec 2019. Available from: URL: https://www.ema.europa.eu/en/news/ema-update-metformin-diabetes-medicines
Health Canada. Health Canada evaluating NDMA in metformin drugs. Internet Document : 5 Dec 2019. Available from: URL: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/71831a-eng.php
MHRA. Metformin diabetes medicines - MHRA Update. Internet Document : 6 Dec 2019. Available from: URL: https://www.gov.uk/government/news/metformin-diabetes-medicines-mhra-update
HPRA. Diabetes medicines - metformin update. Internet Document : 6 Dec 2019. Available from: URL: https://www.hpra.ie/homepage/medicines/news-events/item?t=/diabetes-medicines---metformin-update&id=6fb60c26-9782-6eee-9b55-ff00008c97d0
Rights and permissions
About this article
Cite this article
Nitrosamine impurities in metformin. Reactions Weekly 1784, 6 (2019). https://doi.org/10.1007/s40278-019-72725-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-72725-3